Overview

Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.

NDC labeler codes
50881, 73535
Strengths
Tafasitamab 200 mg/5mL; Axatilimab 9 mg/.9mL; Axatilimab 22 mg/2.2mL; Ruxolitinib 11 mg/1; Ruxolitinib 22 mg/1; Ruxolitinib 33 mg/1; Ruxolitinib 44 mg/1; Ruxolitinib 55 mg/1; Axatilimab 22 mg/.44mL; Axatilimab 9 mg/.18mL; Retifanlimab 25 mg/mL; Ruxolitinib phosphate 15 mg/g; Pemigatinib 4.5 mg/1; Pemigatinib 9 mg/1; Pemigatinib 13.5 mg/1; Ruxolitinib 5 mg/1; Ruxolitinib 10 mg/1; Ruxolitinib 15 mg/1; Ruxolitinib 20 mg/1; Ruxolitinib 25 mg/1
Dosage forms
Tablet, Injection, Tablet, Extended release, Injection, Powder, Lyophilized, For solution, Cream
Routes
Oral, Intravenous, Topical
Drug classes (FDA established)
Kinase Inhibitor, Janus Kinase Inhibitor, Colony Stimulating Factor-1 Receptor Blocker, Programmed Death Receptor-1 Blocking Antibody
HCPCS / J-code
None in Med-Code's directory for these products
Package NDCs
25

NDC codes

Newest listings first. Each row links to the product’s NDC page.

Incyte Corporation NDC Codes: finished products
ProductStrengthForm · routeProduct NDCPackage NDCs (11-digit)HCPCS
Niktimvoaxatilimab-csfrAxatilimab 9 mg/.9mLInjectionIntravenous50881-03650881-0036-17—
Niktimvoaxatilimab-csfrAxatilimab 22 mg/2.2mLInjectionIntravenous50881-04750881-0047-18—
Jakafi XRruxolitinibRuxolitinib 11 mg/1Tablet, Extended releaseOral50881-01150881-0011-08—
Jakafi XRruxolitinibRuxolitinib 22 mg/1Tablet, Extended releaseOral50881-02250881-0022-08—
Jakafi XRruxolitinibRuxolitinib 33 mg/1Tablet, Extended releaseOral50881-03350881-0033-08—
Jakafi XRruxolitinibRuxolitinib 44 mg/1Tablet, Extended releaseOral50881-04450881-0044-08—
Jakafi XRruxolitinibRuxolitinib 55 mg/1Tablet, Extended releaseOral50881-05550881-0055-08—
Niktimvoaxatilimab-csfrAxatilimab 22 mg/.44mLInjectionIntravenous50881-02350881-0023-11—
Niktimvoaxatilimab-csfrAxatilimab 9 mg/.18mLInjectionIntravenous50881-03450881-0034-12—
Zynyzretifanlimab-dlwrRetifanlimab 25 mg/mLInjectionIntravenous50881-00650881-0006-03—
OpzeluraruxolitinibRuxolitinib phosphate 15 mg/gCreamTopical50881-00750881-0007-0450881-0007-0550881-0007-07+1 more—
Monjuvitafasitamab-cxixTafasitamab 200 mg/5mLInjection, Powder, Lyophilized, For solutionIntravenous73535-20873535-0208-01—
Monjuvitafasitamab-cxixTafasitamab 200 mg/5mLInjection, Powder, Lyophilized, For solutionIntravenous50881-01350881-0013-03—
PemazyrepemigatinibPemigatinib 4.5 mg/1TabletOral50881-02650881-0026-01—
PemazyrepemigatinibPemigatinib 9 mg/1TabletOral50881-02750881-0027-01—
PemazyrepemigatinibPemigatinib 13.5 mg/1TabletOral50881-02850881-0028-01—
JakafiruxolitinibRuxolitinib 5 mg/1TabletOral50881-00550881-0005-60—
JakafiruxolitinibRuxolitinib 10 mg/1TabletOral50881-01050881-0010-0150881-0010-60—
JakafiruxolitinibRuxolitinib 15 mg/1TabletOral50881-01550881-0015-60—
JakafiruxolitinibRuxolitinib 20 mg/1TabletOral50881-02050881-0020-60—
JakafiruxolitinibRuxolitinib 25 mg/1TabletOral50881-02550881-0025-60—

Incyte Corporation: common questions

What is Incyte Corporation's NDC labeler code?
50881, 73535. The labeler code is the first segment of each NDC. About labeler codes.
Is there a J-code for Incyte Corporation?
Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
Which NDC goes on a claim?
The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in
Incyte Corporation NDC Codes | National Drug Codes | Med-Code